Union Health Ministry brings pregabalin under Schedule H1 to prevent misuse
The Union Health Ministry has classified pregabalin under Schedule H1 to combat its misuse. This decision follows reports of abuse, particularly among youth, highlighting the drug's sedative and euphoric effects. The new regulations require prescriptions for sales and impose stricter monitoring and penalties for violations.
- ▪Pregabalin is now classified under Schedule H1 due to misuse concerns.
- ▪The drug is commonly prescribed for chronic pain and neurological conditions.
- ▪Retailers must maintain a register of prescriptions and sales for pregabalin.
Opening excerpt (first ~120 words) tap to expand
The Union Health Ministry has brought pregabalin, a drug used for treating chronic pain and certain neurological conditions, under the stricter Schedule H1 category amid reports of its misuse and abuse. The Ministry notified the inclusion of pregabalin under Schedule H1 of the Drugs Rules, 1945, through a gazette notification on May 20."The decision has been taken in view of reports received from certain States regarding the misuse and abuse of Pregabalin, particularly among youth," the Ministry said.The drug, which is prescribed for the treatment of chronic pain, neuropathies, fibromyalgia, and certain neurological conditions, has reportedly been misused for its sedative, euphoric, and dissociative effects.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Hindu — Top.
Discussion
0 commentsMore from The Hindu — Top
